4//SEC Filing
BOSHOFF CHRISTOFFEL 4
Accession 0001225208-25-002397
CIK 0000078003other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 6:58 PM ET
Size
19.1 KB
Accession
0001225208-25-002397
Insider Transaction Report
Form 4
PFIZER INCPFE
BOSHOFF CHRISTOFFEL
President, R&D
Transactions
- Exercise/Conversion
Common Stock
2025-02-22$30.17/sh+8,741$263,716→ 159,085 total - Tax Payment
Common Stock
2025-02-22$26.08/sh−7,798$203,372→ 150,947 total - Tax Payment
Common Stock
2025-02-23$26.30/sh−662$17,411→ 150,285 total - Tax Payment
Common Stock
2025-02-22$26.30/sh−340$8,942→ 158,745 total - Exercise/Conversion
Stock Appreciation Rights
2025-02-22−8,741→ 0 totalExercise: $30.17From: 2025-02-22Exp: 2025-02-22→ Common Stock (8,741 underlying)
Holdings
- 664(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 21, 2025.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001988687
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 6:58 PM ET
- Size
- 19.1 KB